Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-044536
Filing Date
2018-12-04
Accepted
2018-12-04 16:05:07
Documents
1
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6793
  Complete submission text file 0001140361-18-044536.txt   8183
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Schobel Alexander Mark (Reporting) CIK: 0001406836 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 181216858